{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:10:42Z","timestamp":1790644242499,"version":"4.1.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Caring for athletes with cardiac disease requires an approach that caters to the specific needs of the athlete.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 27-year-old professional rugby player was admitted with decompensated heart failure and atrial fibrillation (AF). Transthoracic echocardiogram showed features in keeping with a dilated cardiomyopathy with severe left ventricular (LV) systolic impairment. He made good progress on evidence-based heart failure medication and his LV systolic function returned to normal. He failed to maintain sinus rhythm with cardioversion and remained in persistent AF. He then suffered a transient ischaemic attack despite appropriate anticoagulation. At 1-year follow-up, he was asymptomatic and against medical advice continued to play competitive rugby whilst taking rivaroxaban. He subsequently underwent implantation with a percutaneous left atrial appendage occlusion device, allowing him to discontinue anticoagulation, reduce his bleeding risk and resume his career, whilst simultaneously lowering the thromboembolic risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Counselling should include different management options aimed at minimizing the risks to athletes if they to return to competitive sports. Left atrial appendage occlusion devices are a suitable AF-related stroke prevention strategy in athletes competing in full-contact sports.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytz242","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T01:17:38Z","timestamp":1580260658000},"page":"1-5","source":"Crossref","is-referenced-by-count":2,"title":["Game changer? A sporting indication to implant a left atrial appendage closure device in a rugby player with atrial fibrillation: a case report"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9145-6374","authenticated-orcid":false,"given":"Andre","family":"Briosa e Gala","sequence":"first","affiliation":[{"name":"Department of Cardiology, Oxford University Hospital NHS Foundation Trust, Headley Way, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cox","sequence":"first","affiliation":[{"name":"Department of Cardiology, Oxford University Hospital NHS Foundation Trust, Headley Way, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4166-3746","authenticated-orcid":false,"given":"Michael","family":"Pope","sequence":"first","affiliation":[{"name":"Department of Cardiology, Oxford University Hospital NHS Foundation Trust, Headley Way, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9063-9905","authenticated-orcid":false,"given":"Timothy","family":"Betts","sequence":"first","affiliation":[{"name":"Department of Cardiology, Oxford University Hospital NHS Foundation Trust, Headley Way, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"2020022804013177200_ytz242-B1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/ehy730","article-title":"Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)","volume":"40","author":"Pelliccia","year":"2019","journal-title":"Eur Heart J"},{"key":"2020022804013177200_ytz242-B2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2020022804013177200_ytz242-B3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1","volume":"65","author":"Friberg","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2020022804013177200_ytz242-B4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/STROKEAHA.115.012609","article-title":"Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2-VASc score of 1: systematic review and meta-analysis","volume":"47","author":"Joundi","year":"2016","journal-title":"Stroke"},{"key":"2020022804013177200_ytz242-B5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.mayocp.2018.09.025","article-title":"Left atrial appendage occlusion for the unmet clinical needs of stroke prevention in nonvalvular atrial fibrillation","volume":"94","author":"Holmes","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"2020022804013177200_ytz242-B6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4070\/kcj.2018.0231","article-title":"Left atrial appendages occlusion: current status and prospective","volume":"48","author":"Sharma","year":"2018","journal-title":"Korean Circ J"},{"key":"2020022804013177200_ytz242-B7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"2020022804013177200_ytz242-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2020022804013177200_ytz242-B9","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","article-title":"Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis","volume":"65","author":"Holmes","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2020022804013177200_ytz242-B10","first-page":"190","article-title":"European Heart Rhythm Association (EHRA)\/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS","volume":"19","author":"Gorenek","year":"2016","journal-title":"Europace"},{"key":"2020022804013177200_ytz242-B11","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1093\/eurheartj\/eht188","article-title":"Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study","volume":"34","author":"Andersen","year":"2013","journal-title":"Eur Heart J"},{"key":"2020022804013177200_ytz242-B12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacep.2017.03.019","article-title":"Atrial fibrillation in athletes: a lesson in the virtue of moderation","volume":"3","author":"Estes","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2020022804013177200_ytz242-B13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.hjr.0000239465.26132.29","article-title":"Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers","volume":"13","author":"Heidbuchel","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2020022804013177200_ytz242-B14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/4\/1\/1\/32678229\/ytz242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/4\/1\/1\/32678229\/ytz242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T04:01:44Z","timestamp":1582862504000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/4\/1\/1\/5716502"}},"subtitle":[],"editor":[{"given":"Sabiha","family":"Gati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"David","family":"Niederseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Jonathan M","family":"Behar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Stefan","family":"Simovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Peysh A","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,29]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytz242","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2020,1,29]]}}}